1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Market Study on Uveitis Treatment: Asia to Witness fastest Growth by 2020

Global Market Study on Uveitis Treatment: Asia to Witness fastest Growth by 2020

  • April 2015
  • 92 pages
  • ID: 3175796
  • Format: PDF
  • By Persistence Market Research

Summary

Table of Contents

Uveitis, also known as intraocular inflammation, refers to swelling of the middle layer of the eye, commonly known as uvea. Uveitis is common across all age groups, although it is more prevalent in the age group of 20 years - 50 years. Autoimmune disorders, injuries, inflammatory disorders, and surgeries are some common causes of uveitis. Anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis are the common types of uveitis; among these, anterior uveitis is the most common type of uveitis. Uveitis may be acute, chronic, or recurrent. Common symptoms associated with uveitis include blurred vision, eye pain, eye floaters, redness of the eye, and increased sensitivity to light. Treatment for uveitis varies according to the type of uveitis and primarily helps reduce the pain, subdue inflammation, control tissue damage, and restore vision. Anti-inflammatory medication, antibiotics, and immunosuppressive medications are common treatments available for the disease. Corticosteroid and topical cyclosporine medications are most commonly used to treat uveitis.

North America dominates the global market for uveitis treatment. This is primarily due to rising incidence of uveitis and related disorders, increasing aging population, and growing R&D investments by drug manufacturing companies in the region. Moreover, rising awareness about uveitis is also boosting the growth of the market. The market in Asia is expected to exhibit rapid growth over the next five years. Japan and China are expected to be the fastest growing uveitis treatment markets in the Asian region. Furthermore, the uveitis treatment market in India is also growing due to rising number of uveitis cases and increasing aging population. Some of the key driving forces for uveitis treatment market in emerging countries are the rise in disposable income and a large pool of patients.

In recent times, treatment options for uveitis have increased such as corticosteroids and anti-inflammatory drugs due to rising in number of uveitis cases. The increasing prevalence of eye disorders and rising R&D investments in drug discovery and development are also fueling the growth of the global uveitis treatment market. On the other hand, lack of awareness about eye disorders and poor primary healthcare infrastructure coupled with a lack of health insurance in developing countries are restraining the growth of the uveitis treatment market. Increasing usage of anti-TNF-alpha inhibitor therapy is a recent trend in the global uveitis treatment market. Strong product pipeline and development of molecules from the newer class of uveitis treatment are expected to create opportunities for the growth of the global uveitis treatment market.

This report provides in-depth analysis and estimation of the uveitis treatment market for the period 2014–2020, considering 2013 as the base year for the calculation. Moreover, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report. The uveitis treatment market is categorized on the basis of type, treatment, and geography. Based on the type of uveitis, the market comprises anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis. Based on treatment, uveitis treatment includes anti-inflammatory medication, antibiotic/antiviral medication, and immunosuppressive medications. On the basis of geography, the report identifies and analyzes the market size and predictions for North America, Europe, Asia, and Rest of the World (RoW).

Some of the major players in the uveitis treatment market are pSivida Corp., XOMA Corporation, Alcon, Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc., OphthaliX Inc., Bausch & Lomb Incorporated, Regeneron Pharmaceuticals, Inc, and Santen Pharmaceutical Co., Ltd. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($4900)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Western Equine Encephalitis - Pipeline Review, H2 2019

Western Equine Encephalitis - Pipeline Review, H2 2019

  • $ 2000
  • December 2019

Western Equine Encephalitis - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Western Equine Encephalitis - Pipeline Review, H2 2019, provides an overview ...

Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020

"Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Bacteremia. The marketed products information ...

Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020

"Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Chronic Plaque Psoriasis. ...


ref:plp2015

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on